Youngor(SH:600177) Sou Hu Cai Jing·2025-08-12 06:55Core Viewpoint - The China Securities Regulatory Commission (CSRC) has requested Shanghai Linqingxuan Biotechnology Co., Ltd. to provide supplementary materials regarding administrative penalties for false advertising and the transfer of shares involving new shareholders as the company prepares for its overseas listing [1][12]. Financial Performance - Linqingxuan achieved revenues of 691.5 million RMB, 805 million RMB, and 1.21 billion RMB for the years 2022, 2023, and 2024 respectively, with net profits of -5.93 million RMB, 84.5 million RMB, and 186.8 million RMB during the same period [5][6]. - The company reported a significant increase in sales, with a notable rise in gross profit from 539.1 million RMB in 2022 to 997.7 million RMB in 2024 [6]. Product Dependency - The company has a growing reliance on a single product category, with sales of essence oil products accounting for 31.5%, 35.3%, and 37.0% of total sales from 2022 to 2024 [6][8]. - Linqingxuan's primary brand contributes to 99.1%, 99.0%, and 99.0% of total revenue during the same period, indicating a significant dependency on its flagship brand [8]. Marketing and R&D Expenditure - Marketing expenses have been significantly higher than R&D costs, with sales and distribution expenses amounting to 5.09 billion RMB, 4.86 billion RMB, and 6.88 billion RMB, representing 73.66%, 60.37%, and 56.86% of revenues respectively [11]. - In 2024, marketing and promotional expenses reached approximately 365 million RMB, which is 12 times the R&D expenditure of 30.4 million RMB [11]. Regulatory and Compliance Issues - Linqingxuan faced penalties for false advertising, specifically for claims regarding anti-aging effects that did not align with actual product capabilities, leading to a fine of over 21,000 RMB [12]. - The CSRC has requested clarification on the company's compliance with regulations following these penalties and the implications for its upcoming listing [12][15]. Shareholder Changes - Recently, the company welcomed a new shareholder, Youngor Fashion Technology Co., Ltd., which acquired a 4.491% stake, becoming the fourth largest shareholder [14]. - The CSRC has also requested details regarding the pricing and rationale behind recent share transfers involving new shareholders [15].